Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triferic in Pediatric ESRD Patients
NCT04239391Phase 3Unknown
- Sponsor
- Rockwell Medical
- Start
- Sep 2020
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of ferric pyrophosphate in anemia of chronic kidney disease (CKD-A), sponsored by Rockwell Medical. Status: unknown.
02
Drugs
ferric pyrophosphate
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04239391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04239391.